window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

drug discovery

  • Digital & Data,Drug Discovery & Development,Research & Development

    Basecamp integrates AI antibiotic and vaccine design models into Claude Science

    Basecamp Research has integrated its EDEN antibiotic design and vaccine [...]

    July 2, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain,Research & Development

    Genoskin expands US production of primary human mast cells

    Genoskin is expanding its US operations with a new laboratory [...]

    June 30, 2026
  • Drug Discovery & Development,Research & Development

    FairJourney Bio expands antibody discovery offering through AbTherx partnership

    FairJourney Bio has partnered with AbTherx to bring transgenic mouse-based [...]

    June 25, 2026
  • Advanced Therapies,Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development

    TRIMTECH raises $14M to advance protein degradation therapies for neurodegenerative diseases

    TRIMTECH Therapeutics has secured an additional $14 million in seed [...]

    June 23, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Lonza licenses dual-payload ADC technology to Antharis for GI cancers

    Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

    June 16, 2026
  • Biotech & Pharma Business,Drug Discovery & Development

    ZoBio launches DNA-encoded library hit discovery service for difficult drug targets

    ZoBio has launched a DNA-encoded library (DEL) hit discovery service [...]

    June 16, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Poolbeg presents preclinical POLB 001 data at EHA Congress

    Poolbeg Pharma has presented two posters at the European Hematology [...]

    June 11, 2026
  • Pharmaceuticals and therapeutics,Therapeutic Areas

    Scenic Biotech joins Michael J. Fox Foundation Parkinson’s research programme

    Scenic Biotech has joined the Michael J. Fox Foundation’s LRRK2 [...]

    June 11, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics

    Scripps researchers develop stereoretentive radical chemistry for drug discovery

    Scientists at Scripps Research have developed a new chemical reaction [...]

    June 11, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    PhoreMost advances brain cancer candidate PMC-001 towards Phase 1

    PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

    June 11, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Icosagen completes €45M biologics manufacturing expansion
    Categories: Advanced Therapies, Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • Poolbeg secures South African patent for POLB 001
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development
  • Lonza expands HPAPI capacity to support ADC manufacturing
    Categories: Advanced Therapies, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top